Nanollose Limited (ASX:NC6) Investor Presentation
Nanollose Limited (ASX:NC6) (FRA:N0L) is commercialising scalable technology to create tree-free fibres with minimal environmental impact.
Companies in the News
Biotech
IQX Limited (NSX:IQX) Worldwide License for Harvard Uni's eRapid Technology
iQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvard's Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
VIDEO: Nanollose Limited (ASX:NC6) Executive Chairman Dr. Wayne Best Explains the Virtues of Bio Responsible Textiles
Nanollose Limited (ASX:NC6) Executive Chairman explains the environmentally friendly textile produced by the company for application in the fashion industry.
Nanollose Limited (ASX:NC6) Successful Completion of Pilot Spin
Nanollose Limited (ASX:NC6) (FRA:N0L) is pleased to advise that it has achieved a significant milestone in its technology commercialisation strategy, following the successful completion of its first pilot scale spin of a Nullarbor lyocell fibre.
VGI Health Technology Limited (NSX:VTL) Executes Agreement with Continuum Sciences LLC
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly-owned US subsidiary, Invictus Nutraceuticals, Inc. (IVN), has executed a Sales Representative Agreement with Continuum Sciences LLC of Colorado.
VGI Health Technology Limited (NSX:VTL) Dr Moon to present at Experimental Biology Conference
VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting two abstracts at the American Physiological Society's (APS) Annual Meeting Experimental Biology Conference 2022 in Philadelphia, USA.
VGI Health Technology Limited (NSX:VTL) Term Sheet for Sale of Invictus BioPharma Group
VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has executed a non-binding Term Sheet for the sale of its wholly owned subsidiary, the Invictus BioPharma Pty Ltd Group to Invictus BioPharma Holdings Ltd.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
- NSX Limited (ASX:NSX) Appointment of Managing Director and CEO - Max Cunningham
Social Media
